South Korean Fair Trade Commission Investigates Drug Makers For Offering Unethical Financial Incentives To Hospitals
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's Fair Trade Commission is in the final stages of investigations into seven pharmaceutical companies including five foreign pharma companies in a series of complaints from civic groups that drug makers were offering financial incentives to hospitals and doctors to give priority to their products